Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00427141 | A Three-Part Study Of GSK580416 In Healthy Subjects | PHASE1 | COMPLETED | 48 | — | — | Oct 1, 2006 | - | Jun 4, 2012 | 1 | Australia |
| Name | Type | Description |
|---|---|---|
| GSK580416 | DRUG | - |
Inclusion criteria: * Healthy as determined by a physician * Healthy male or female of non-child bearing potential between 18 and 55 years of age (inclusive) * Body weight \> = 50 kg and BMI between 19 and 30 kg/m2 (inclusive) Exclusion criteria: * Positive HIV antibody, Hepatitis B surface antig...